<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Dose Response</journal-id><journal-id journal-id-type="iso-abbrev">Dose Response</journal-id><journal-id journal-id-type="hwp">spdos</journal-id><journal-id journal-id-type="publisher-id">DOS</journal-id><journal-title-group><journal-title>Dose-Response</journal-title></journal-title-group><issn pub-type="epub">1559-3258</issn><publisher><publisher-name>SAGE Publications</publisher-name><publisher-loc>Sage CA: Los Angeles, CA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">35422680</article-id><article-id pub-id-type="pmc">PMC9002358</article-id><article-id pub-id-type="publisher-id">10.1177_15593258221082896</article-id><article-id pub-id-type="doi">10.1177/15593258221082896</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Evaluation of AI-Based Segmentation Tools for COVID-19 Lung Lesions
on Conventional and Ultra-low Dose CT Scans</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3676-0664</contrib-id><name><surname>Aiello</surname><given-names>Marco</given-names></name><xref rid="aff1-15593258221082896" ref-type="aff">1</xref><xref rid="corresp1-15593258221082896" ref-type="corresp"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7464-4499</contrib-id><name><surname>Baldi</surname><given-names>Dario</given-names></name><xref rid="aff1-15593258221082896" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Esposito</surname><given-names>Giuseppina</given-names></name><xref rid="aff2-15593258221082896" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Valentino</surname><given-names>Marika</given-names></name><xref rid="aff3-15593258221082896" ref-type="aff">3</xref><xref rid="aff4-15593258221082896" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Randon</surname><given-names>Marco</given-names></name><xref rid="aff2-15593258221082896" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Salvatore</surname><given-names>Marco</given-names></name><xref rid="aff1-15593258221082896" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3297-2213</contrib-id><name><surname>Cavaliere</surname><given-names>Carlo</given-names></name><xref rid="aff1-15593258221082896" ref-type="aff">1</xref></contrib><aff id="aff1-15593258221082896"><label>1</label><institution-wrap><institution content-type="university">IRCCS SDN</institution></institution-wrap>, Naples, Italy</aff><aff id="aff2-15593258221082896"><label>2</label><institution-wrap><institution content-type="university">Bio Check Up S.r.l</institution></institution-wrap>, Naples, Italy</aff><aff id="aff3-15593258221082896"><label>3</label><institution-wrap><institution content-type="university">Istituto di Scienze Applicate e
Sistemi Intelligenti &#x0201c;Eduardo Caianiello&#x0201d; (ISASI-CNR)</institution></institution-wrap>, Pozzuoli, Italy</aff><aff id="aff4-15593258221082896"><label>4</label><institution-wrap><institution content-type="university">Universit&#x000e0; Degli Studi di Napoli
Federico II</institution></institution-wrap>, Dip. di Ingegneria Elettrica e Delle Tecnologie
Dell'Informazione, Italy</aff></contrib-group><author-notes><corresp id="corresp1-15593258221082896">Marco Aiello, IRCCS SDN, Via Emanuele
Gianturco, Naples 80143, Italy. Email:
<email>marco.aiello@synlab.it</email></corresp></author-notes><pub-date pub-type="epub"><day>6</day><month>4</month><year>2022</year></pub-date><pub-date pub-type="collection"><season>Apr-Jun</season><year>2022</year></pub-date><volume>20</volume><issue>2</issue><elocation-id>15593258221082896</elocation-id><history><date date-type="received"><day>7</day><month>9</month><year>2021</year></date><date date-type="accepted"><day>4</day><month>2</month><year>2022</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder content-type="sage">SAGE Publications</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the Creative Commons
Attribution-NonCommercial 4.0 License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which
permits non-commercial use, reproduction and distribution of the work
without further permission provided the original work is attributed as
specified on the SAGE and Open Access pages (<ext-link ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p></license></permissions><abstract><p> A reliable diagnosis and accurate monitoring are pivotal steps for treatment and
prevention of COVID-19. Chest computed tomography (CT) has been considered a
crucial diagnostic imaging technique for the injury assessment of the viral
pneumonia. Furthermore, the automatization of the segmentation methods for lung
alterations helps to speed up the diagnosis and lighten radiologists&#x02019; workload.
Considering the assiduous pathology monitoring, ultra-low dose (ULD) chest CT
protocols have been implemented to drastically reduce the radiation burden.
Unfortunately, the available AI technologies have not been trained on ULD-CT
data and validated and their applicability deserves careful evaluation.
Therefore, this work aims to compare the results of available AI tools (BCUnet,
CORADS AI, NVIDIA CLARA Train SDK and CT Pneumonia Analysis) on a dataset of 73
CT examinations acquired both with conventional dose (CD) and ULD protocols.
COVID-19 volume percentage, resulting from each tool, was statistically
compared. This study demonstrated high comparability of the results on CD-CT and
ULD-CT data among the four AI tools, with high correlation between the results
obtained on both protocols (R &#x0003e; .68, P &#x0003c; .001, for all AI tools).</p></abstract><kwd-group><kwd>COVID-19</kwd><kwd>segmentation algorithms</kwd><kwd>ultra-low dose</kwd><kwd>deep learning</kwd><kwd>artificial intelligence</kwd></kwd-group><funding-group specific-use="FundRef"><award-group id="award1-15593258221082896"><funding-source id="funding1-15593258221082896">
<institution-wrap><institution>Regione Campania</institution><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100003852</institution-id></institution-wrap>
</funding-source><award-id rid="funding1-15593258221082896">D54I20001410002</award-id></award-group><award-group id="award2-15593258221082896"><funding-source id="funding2-15593258221082896">
<institution-wrap><institution>Ministero della Salute</institution><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100003196</institution-id></institution-wrap>
</funding-source><award-id rid="funding2-15593258221082896">Ricerca corrente IRCCS</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>cover-date</meta-name><meta-value>April-June 2022</meta-value></custom-meta><custom-meta><meta-name>typesetter</meta-name><meta-value>ts10</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-15593258221082896"><title>Introduction</title><p>COVID-19 is an infectious disease caused by a newly discovered coronavirus
(SARS-CoV-2) and it is an ongoing pandemic. It has spread since January 2020 and up
to early March 2021 has infected 130, 509,866 people worldwide, with 45,919,941
confirmed cases only in Europe.<sup>
<xref rid="bibr48-15593258221082896" ref-type="bibr">1</xref>
</sup> The clinical presentation of SARS-CoV-2 infection can range from asymptomatic
to moderate or severe symptoms&#x02014;such as fever, cough, weakness, loss of smell, and
taste&#x02014;respiratory disease and, less frequently, gastro-enteritis or neurological
symptoms.</p><p>The gold standard for COVID-19 detection is the Reverse-Transcription-Polymerase
Chain Reaction (RT-PCR) test. Different studies reported that RT-PCR technique has a
high false negative rate and low sensitivity,<sup>
<xref rid="bibr1-15593258221082896" ref-type="bibr">2</xref>
</sup> due to its variability in lab execution. In the cases of patients with
suspected coronavirus infection, with negative RT-PCR test or waiting for swab
responses, chest CT was used to speed up diagnosis times and to isolate the patient
from the rest of the community. CT diagnostic technique, as a non-invasive imaging
approach, is able to detect some characteristic features in the lung lesions
COVID-19 associated, for example, ground glass opacities, rounded opacities, and
enlarged intra-infiltrate vessels.<sup><xref rid="bibr2-15593258221082896" ref-type="bibr">3</xref>,<xref rid="bibr3-15593258221082896" ref-type="bibr">4</xref></sup> The chest X-ray has often
proved pathology (59% of cases) in asymptomatic or paucisymptomatic subjects after
14&#x000a0;days of quarantine, even in the absence of a nasopharyngeal swab.<sup>
<xref rid="bibr4-15593258221082896" ref-type="bibr">5</xref>
</sup> In summer 2020, multidisciplinary panels of experts in patient management
published guidelines for support the use of chest CT for COVID-19 patients with
worsening respiratory status,<sup>
<xref rid="bibr5-15593258221082896" ref-type="bibr">6</xref>
</sup> as well as the WHO.<sup>
<xref rid="bibr49-15593258221082896" ref-type="bibr">7</xref>
</sup> Over the past decades, CT has become an important imaging technique, but it
is also a major contributor to individual and collective radiation dose. For patient
protection, CT dose is recommended to be as low as reasonably achievable to meet
clinical needs.<sup>
<xref rid="bibr6-15593258221082896" ref-type="bibr">8</xref>
</sup> Technical progress including automated exposure control helps to optimize the
relationship between image noise and radiation dose. Correspondingly, automated
exposure control with tube current modulation has been developed for CT.<sup><xref rid="bibr7-15593258221082896" ref-type="bibr">9</xref>,<xref rid="bibr8-15593258221082896" ref-type="bibr">10</xref></sup> Moreover, adult scanning can
be adjusted according to body weight (the smaller the bodies, the lesser the dose;
instead, the larger the bodies, the higher the dose), resulting in excellent
diagnostic scans.<sup>
<xref rid="bibr9-15593258221082896" ref-type="bibr">11</xref>
</sup> All these last assertions have been confirmed, advocating the proper
implementation, especially for chest scanning.<sup><xref rid="bibr10-15593258221082896" ref-type="bibr">12</xref><xref rid="bibr11-15593258221082896" ref-type="bibr"/><xref rid="bibr12-15593258221082896" ref-type="bibr"/><xref rid="bibr13-15593258221082896" ref-type="bibr"/><xref rid="bibr14-15593258221082896" ref-type="bibr"/>-<xref rid="bibr15-15593258221082896" ref-type="bibr">17</xref></sup> The optimal image quality
level for CT examinations stands for the level at which diagnostic images can
reliably be produced using the lowest dose level and it should be tailored according
to each individual patient and relevant cathegorized groups (e.g., pediatric, or
obese patients). Thus, to reduce radiological risks and dose, ULD-CT protocols have
been evaluated in recent decades.<sup>
<xref rid="bibr16-15593258221082896" ref-type="bibr">18</xref>
</sup></p><p>To date, according to the authors' knowledge, very few studies have been published
regarding dosimetry in ULD-CT protocols, and nothing that directly compares ULD-CT
to both CD-CT and radiography. Schaal et al. estimated an average effective dose of
.25&#x000a0;mSv based on exposure data from 55 patients, but lack of information about the
size of the patients adds uncertainty to this estimate.<sup>
<xref rid="bibr17-15593258221082896" ref-type="bibr">19</xref>
</sup> In emergent situations such as COVID-19 pandemic, the demand for performing
CT scans may significantly increase due to the high rate of infected
individuals.</p><p>The sequential and multiple acquisitions of CT exams can significantly increase the
cumulative radiation dose these patients may receive during their hospitalization
and recovery. Replacing CD-CT with ULD-CT has been proposed as a method to decrease
radiation exposure. In a retrospective study,<sup>
<xref rid="bibr18-15593258221082896" ref-type="bibr">20</xref>
</sup> a low dose CT (LD-CT) combined with iterative reconstruction demonstrated
sensitivity, specificity, positive predictive value, negative predictive value, and
accuracy of about 90% in the diagnosis of COVID-19. Furthermore, ULD-CT protocols
proved an additive diagnostic benefit in patients with concomitant bacterial
pneumonia or an alternative diagnosis other than COVID-19.</p><p>Recently, artificial intelligence (AI) techniques&#x02014;in particular deep learning (DL)
algorithms&#x02014;have shown great potential in the medical imaging sector thanks to their
high ability to extract both morphological and functional features.<sup><xref rid="bibr19-15593258221082896" ref-type="bibr">21</xref><xref rid="bibr20-15593258221082896" ref-type="bibr"/>-<xref rid="bibr21-15593258221082896" ref-type="bibr">23</xref></sup> In particular, such
techniques have been applied to detect and differentiate bacterial and viral
pneumonia in pediatric chest radiographs.<sup><xref rid="bibr22-15593258221082896" ref-type="bibr">24</xref>,<xref rid="bibr23-15593258221082896" ref-type="bibr">25</xref></sup> Besides, a retrospective and
multicenter study regarding the application of DL technique to differentiate
coronavirus pneumonia from other lung diseases was recently published.<sup>
<xref rid="bibr24-15593258221082896" ref-type="bibr">26</xref>
</sup> Harmon et al. show that DL algorithms, trained in a diverse multinational
cohort, can achieve up to 90.8% accuracy, with 84% sensitivity and 93% specificity.<sup>
<xref rid="bibr25-15593258221082896" ref-type="bibr">27</xref>
</sup> Wang et al. uncovered some DL and radiomic features that contribute to
differentiation of COVID-19 from non-COVID-19 viral pneumonia.<sup>
<xref rid="bibr26-15593258221082896" ref-type="bibr">28</xref>
</sup> As a consequence of DL techniques development to support the diagnosis of
COVID-19 on CT scans, several tools based on AI models trained on image datasets
acquired with CD-CT protocol have been made available to the clinical and research
community. The aim of this work is to evaluate the applicability of these tools also
in the domain of low-dose CT images (ULD).</p></sec><sec sec-type="materials|methods" id="sec2-15593258221082896"><title>Materials and Methods</title><sec id="sec3-15593258221082896"><title>Patients</title><p>73 patients (41 female, age range: 52.91 &#x000b1;16.40 (mean age &#x000b1; standard deviation))
were informed and prospectively enrolled for the research protocol approved by
the local ethical committee of IRCCS SDN (Comitato etico IRCCS Pascale, Naples,
project identification code: 7_20). The protocol was adopted to face the
pandemic situation. Inclusion criteria were the prescription of a chest CT for
post-COVID-19 screening, suspect COVID-19, and generally pulmonary pathology.
Anamnestic and clinical information were collected. Adult patients, with
pulmonary disease or post&#x02013;COVID-19 infection symptoms, who underwent baseline,
unenhanced chest CT (according to clinical needs) on the third-generation dual
source CT. Exclusion criteria were patients with a BMI greater than 30 and
children and adolescents under 18&#x000a0;years.</p></sec><sec id="sec4-15593258221082896"><title>CT Acquisition and Reconstruction</title><p>Patients lay in a head-first supine position during non-enhanced consecutive
acquisition CT protocols (CD-CT followed by ULD-CT). All patients underwent LD
chest CT by using a SOMATOM FORCE (Siemens Healthineers, Forchheim, Germany)
slice .6&#x000a0;mm detector scanner. No contrast agent was admitted. The CD-CT
acquisition parameters were as follows: tube voltage of reference 120&#x000a0;kVp, tube
current of reference 61&#x000a0;mAs, and pitch factor of 1.2. The automatic tube current
modulation (CareDose 4&#x000a0;D) system was used and the automatic tube voltage
selection (Care kV) was activated on the &#x0201c;non-enhanced&#x0201d; setting. For ULD-CT
acquisition, both the tubes worked at 100 kVp with .6&#x000a0;mm tin filter (100Sn kVp,
for spectral shaping), with wide collimation (2 &#x000d7; 192 &#x000d7; .6&#x000a0;mm), a rotation time
of .25&#x000a0;s, an ultra-long pitch (pitch = 3, Turbo Flash mode, Siemens
Healthineers), with modulated mA at 70&#x000a0;mAs reference. Effective radiation dose
was calculated by multiplying the dose-length product by .014&#x000a0;mSv/mGy x cm, as
the constant k-value for thoracic imaging. For both protocols, raw data were
reconstructed at 3&#x000a0;mm slice thickness by convolutional nucleus B157, Br54 (Br40,
moderately smooth). To reduce the image noise, Advanced Modeled Iterative
Reconstruction (ADMIRE) strength of 3 was used. All reconstructions were
performed with a matrix size of 512 &#x000d7; 512 pixels. <xref rid="fig1-15593258221082896" ref-type="fig">Figure 1</xref> shows CD-CT and ULD-CT images
of the same patient, where different noise levels can visually appreciate.<fig position="float" fig-type="figure" id="fig1-15593258221082896"><label>Figure 1.</label><caption><p>CD-CT and ULD-CT comparison on the same COVID-19 patient. (a) A CD-CT
axial slice (100kVp, 47&#x000a0;mAs, Bl57), (b) A ULD-CT axial slice
(100kVp, 84&#x000a0;mAs, Bl57).</p></caption><graphic xlink:href="10.1177_15593258221082896-fig1" position="float"/></fig></p></sec><sec id="sec5-15593258221082896"><title>Data Analysis</title><p>For each subject, COVID-19 pneumonia lesion segmentation has been executed on
imaging data acquired with both CD-CT and ULD-CT protocols. Four AI tools based
on deep neural networks have been used: BCUnet, CORADS AI, CT Pneumonia
Analysis, and NVIDIA CLARA Train SDK. All these tools have been validated only
for research purposes and not for clinical use. The architecture and the design
of each AI system are described in the following paragraphs.</p></sec><sec id="sec6-15593258221082896"><title>BCUnet</title><p>BCUnet is a deep neural network for the segmentation of pulmonary lesions in
thoracic non-contrast CT images. The algorithm is based on a U-net architecture.<sup>
<xref rid="bibr27-15593258221082896" ref-type="bibr">29</xref>
</sup> The model has been trained with a supervised DL technique. Each image
included in the dataset is associated with a manual annotation of the lesion.
The training dataset consists of 199 annotated CT images of COVID-19 patients,
provided by the COVID-19 Lung CT Lesion Segmentation Grand Challenge-2020.<sup>
<xref rid="bibr28-15593258221082896" ref-type="bibr">30</xref>
</sup> In particular, the innovative contribution that characterizes BCUnet is
the introduction of an image masking technique and a data augmentation
technique, which provides additional images for training the network by adding
Gaussian noise and images deformed with an atlas-based method. The model was
implemented in Python 3.6, using Tensorflow 2.3 and Keras as frameworks. The
MobileNetV2 network weights have been made available by Tensorflow. The code for
the CLAHE algorithm is contained in the scikit-image library.</p></sec><sec id="sec7-15593258221082896"><title>CORADS AI</title><p>COVID-19 Reporting and Data AI System (CORADS AI) is a standardized chest CT
scoring system that, after segmentation, automatically assigns scores from 1 to
5 that increase with the level of suspicion of COVID-19.<sup>
<xref rid="bibr29-15593258221082896" ref-type="bibr">31</xref>
</sup> This algorithm was developed by the Diagnostic Image Analysis Group,
Amsterdam University Medical Center, Fraunhofer MEVIS, and Thirona. For any
detail, see <ext-link xlink:href="https://grand-challenge.org/algorithms/corads-ai/" ext-link-type="uri">https://grand-challenge.org/algorithms/corads-ai/</ext-link>. In the
following analysis, the used annotation is CORADS.</p></sec><sec id="sec8-15593258221082896"><title>NVIDIA CLARA Train SDK</title><p>Clara Training Framework is a package-level application of NVIDIA Clara Train
Software Development Kit (SDK), a python-based SDK that allows developers to
seek faster implementation of medical-specific DL solutions by leveraging
optimized, ready-to-use and pre-trained built in-house NVIDIA models. These
pre-trained models are packaged as medical model repositories (MMARs) and
contain the scripts needed for model development activities. The collection
includes pre-trained models for CT lung segmentation, COVID-19 classification in
chest studies, and a CT annotated lung model. In this work two CLARA models have
been used:(i) lung segmentation (<ext-link xlink:href="https://ngc.nvidia.com/catalog/models/nvidia:med:clara_train_covid19_ct_lung_seg" ext-link-type="uri">https://ngc.nvidia.com/catalog/models/nvidia:med:clara_train_covid19_ct_lung_seg</ext-link>)
and (ii) COVID-19 CT lesion segmentation (<ext-link xlink:href="https://ngc.nvidia.com/catalog/models/nvidia:med:clara_pt_covid19_ct_lesion_segmentation" ext-link-type="uri">https://ngc.nvidia.com/catalog/models/nvidia:med:clara_pt_covid19_ct_lesion_segmentation</ext-link>).
In the following analysis, the used annotation is CLARA.</p></sec><sec id="sec9-15593258221082896"><title>CT Pneumonia Analysis</title><p>CT Pneumonia Analysis, syngo.via Frontier prototype, is an interactive platform
for pneumonia analysis developed by Siemens Healthineers,<sup>
<xref rid="bibr30-15593258221082896" ref-type="bibr">32</xref>
</sup>
<ext-link xlink:href="https://www.siemens-healthineers.com/medical-imaging/digital-transformation-of-radiology/ai-covid-19-algorithm" ext-link-type="uri">https://www.siemens-healthineers.com/medical-imaging/digital-transformation-of-radiology/ai-covid-19-algorithm</ext-link>)
to automatically identify and quantify hyperdense lung regions on lung CT scans,
facilitating their analysis and evaluation. CT Pneumonia Analysis performs the
automated analysis of pulmonary opacities on axial CT data (section thicknesses
up to 5&#x000a0;mm), with the possibility of introducing, through the manual
segmentation tool, any additions or changes to the automatically generated
masks. In the following analysis the used annotation is Pneumonia.</p></sec></sec><sec id="sec10-15593258221082896"><title>Statistical Analysis</title><p>For each patient, COVID-19 volume percentage (CV%) has been calculated considering
the COVID-19 lung lesion volume on the total lung volume, as obtained by each AI
segmentation tool. The CV% has been estimated on both CD-CT and ULD-CT considering
two different convolutional kernels for image reconstruction, that is, Bl57 and
Br40, maintaining a 3&#x000a0;mm CT slice thickness and a denoise level of three. Under
these conditions, first, a Shapiro test has been implemented to assert the normality
data distribution.<sup>
<xref rid="bibr47-15593258221082896" ref-type="bibr">33</xref>
</sup> Moreover, according to Shapiro results, a Kruskal&#x02013;Wallis (KW) test<sup>
<xref rid="bibr46-15593258221082896" ref-type="bibr">34</xref>
</sup> has been performed to assess the difference between the AI-based segmentation
tools on CD-CT and ULD-CT, with a subsequent Dunn&#x02019;s post hoc test<sup>
<xref rid="bibr45-15593258221082896" ref-type="bibr">35</xref>
</sup> to determine which tools differ. To graphically understand data trend and
distribution relating to single protocols and single AI segmentation algorithms,
boxplots have been realized, denoting the median, the 25th to 75th percentiles
(boxes) and the minimum to the maximum outliers. A quantitative analysis has been
evaluated to prove the correlation between CD and ULD-CT protocols in CV% parameter,
applying the Spearman&#x02019;s correlation coefficient test,<sup>
<xref rid="bibr31-15593258221082896" ref-type="bibr">36</xref>
</sup> figuring the relative heatmap. To strengthen the comparison, the pairwise
Bland-Altman (BA) test<sup>
<xref rid="bibr32-15593258221082896" ref-type="bibr">37</xref>
</sup> has been carried out to describe the agreement between the two quantitative
protocol measurements, that is, CD-CT CV% and ULD-CT CV% values, with respect to AI
tools. To quantify the aforementioned agreement, some constraints have been needed:
the mean and the standard deviation (STD) of the differences between the two
measurements (mean &#x02212;1.96&#x000a0;std/mean +1.96&#x000a0;std). A BA graphical approach has been used.
For the sake of in-depth analysis, all the statistics have been repeated on data
generated by BCUnet and CORADS tools implementing the lung lesion segmentation lobe
by lobe. The lung lobe segmentation has been included because of the importance of
knowing the location and distribution of COVID-19 lung disease, which can help in
determining the most suitable treatment.<sup>
<xref rid="bibr50-15593258221082896" ref-type="bibr">38</xref>
</sup> Under the same previous conditions, CV% has been calculated for each lung
lobe, naming differently as LLL%, the left lower lobe COVID-19 volume percentage;
LUL%, the left upper lobe COVID-19 volume percentage; RLL%, the right lower lobe
COVID-19 volume percentage; RML%, the right medium lobe COVID-19 volume percentage;
and RUL%, the right upper lobe COVID-19 volume percentage. These percentages were
obtained for both protocols (CD-CT and ULD-CT). All the statistical analyses have
been performed using Python libraries, in particular PyCompare module, SciPy
library, Pingouin, and scikit_posthocs packages. The results have been considered
statistically significant for <italic toggle="yes">P</italic>-value less than .05.</p></sec><sec sec-type="results" id="sec11-15593258221082896"><title>Results</title><p>The Shapiro test has been applied to check the normal tendency of data distribution,
including all kernel reconstructions. It has been evaluated per each AI-based
segmentation tool with respect to both protocols. <xref rid="table1-15593258221082896" ref-type="table">Table 1</xref> shows Shapiro test results in
terms of W statistic and <italic toggle="yes">P</italic>-value.<table-wrap position="float" id="table1-15593258221082896"><label>Table 1.</label><caption><p>Shapiro test results, in terms of W statistic and
<italic toggle="yes">P</italic>-value, for all AI-based segmentation tools
considering both CD-CT and ULD-CT protocols.</p></caption><alternatives><graphic xlink:href="10.1177_15593258221082896-table1" specific-use="table1-15593258221082896" position="float"/><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">BCUnet CD</th><th align="center" rowspan="1" colspan="1">BCUnet ULD</th><th align="center" rowspan="1" colspan="1">CORADS CD</th><th align="center" rowspan="1" colspan="1">CORADS ULD</th><th align="center" rowspan="1" colspan="1">CLARA CD</th><th align="center" rowspan="1" colspan="1">CLARA ULD</th><th align="center" rowspan="1" colspan="1">Pneumonia CD</th><th align="center" rowspan="1" colspan="1">Pneumonia ULD</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">W Statistic</td><td align="char" char="." rowspan="1" colspan="1">.971</td><td align="char" char="." rowspan="1" colspan="1">.961</td><td align="char" char="." rowspan="1" colspan="1">.591</td><td align="char" char="." rowspan="1" colspan="1">.681</td><td align="char" char="." rowspan="1" colspan="1">.892</td><td align="char" char="." rowspan="1" colspan="1">.814</td><td align="char" char="." rowspan="1" colspan="1">.663</td><td align="char" char="." rowspan="1" colspan="1">.591</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-value</td><td align="char" char="." rowspan="1" colspan="1">.9028</td><td align="char" char="." rowspan="1" colspan="1">.8203</td><td align="char" char="." rowspan="1" colspan="1">.0001*</td><td align="char" char="." rowspan="1" colspan="1">.0014*</td><td align="char" char="." rowspan="1" colspan="1">.2437</td><td align="char" char="." rowspan="1" colspan="1">.0403*</td><td align="char" char="." rowspan="1" colspan="1">.0009*</td><td align="char" char="." rowspan="1" colspan="1">.0001*</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>*indicates significance with P &#x0003c; .05</p></fn></table-wrap-foot></table-wrap></p><p>As it can be noticed in <xref rid="table1-15593258221082896" ref-type="table">Table
1</xref>, CORADS and Pneumonia data (both CD-CT and ULD-CT) and CLARA ULD-CT
data do not follow a Gaussian distribution (<italic toggle="yes">P</italic>-value &#x0003c; .05).
Since most AI segmentation algorithms have generated non-Gaussian data, all data
have been considered non-parametric.</p><p>The result of the KW test rejects the null hypothesis with a H statistic of 182.19
and <italic toggle="yes">P</italic>-value less than .001, meaning that the used algorithms
differ. Regarding the Dunn&#x02019;s post hoc test, <xref rid="table2-15593258221082896" ref-type="table">Table 2</xref> and <xref rid="table3-15593258221082896" ref-type="table">Table 3</xref> show the obtained results relative
to CD-CT and ULD-CT data, respectively.<table-wrap position="float" id="table2-15593258221082896"><label>Table 2.</label><caption><p>Dunn&#x02019;s test results for all AI-based segmentation tools on CD-CT
data.</p></caption><alternatives><graphic xlink:href="10.1177_15593258221082896-table2" specific-use="table2-15593258221082896" position="float"/><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" rowspan="1" colspan="1">CD-CT <italic toggle="yes">P</italic>-value</th><th align="center" rowspan="1" colspan="1">BCUnet</th><th align="center" rowspan="1" colspan="1">CORADS</th><th align="center" rowspan="1" colspan="1">CLARA</th><th align="center" rowspan="1" colspan="1">Pneumonia</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">BCUnet</td><td align="char" char="." rowspan="1" colspan="1">1.000000e+00</td><td align="char" char="." rowspan="1" colspan="1">4.272311e&#x02212;28<bold>*</bold></td><td align="char" char="." rowspan="1" colspan="1">6.949754e&#x02212;25<bold>*</bold></td><td align="char" char="." rowspan="1" colspan="1">3.915073e&#x02212;29<bold>*</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">CORADS</td><td align="char" char="." rowspan="1" colspan="1">4.272311e&#x02212;28</td><td align="char" char="." rowspan="1" colspan="1">1.000000e+00</td><td align="char" char="." rowspan="1" colspan="1">1.000000e+00</td><td align="char" char="." rowspan="1" colspan="1">1.000000e+00</td></tr><tr><td align="left" rowspan="1" colspan="1">CLARA</td><td align="char" char="." rowspan="1" colspan="1">6.949754e&#x02212;25</td><td align="char" char="." rowspan="1" colspan="1">1.000000e+00</td><td align="char" char="." rowspan="1" colspan="1">1.000000e+00</td><td align="char" char="." rowspan="1" colspan="1">1.000000e+00</td></tr><tr><td align="left" rowspan="1" colspan="1">Pneumonia</td><td align="char" char="." rowspan="1" colspan="1">3.915073e&#x02212;29</td><td align="char" char="." rowspan="1" colspan="1">1.000000e+00</td><td align="char" char="." rowspan="1" colspan="1">1.000000e+00</td><td align="char" char="." rowspan="1" colspan="1">1.000000e+00</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>*indicates significance with P &#x0003c; .01. Highlighted row represents
which algorithm differs.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="table3-15593258221082896"><label>Table 3.</label><caption><p>Dunn&#x02019;s test results for all AI-based segmentation tools on ULD-CT
data.</p></caption><alternatives><graphic xlink:href="10.1177_15593258221082896-table3" specific-use="table3-15593258221082896" position="float"/><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" rowspan="1" colspan="1">ULD-CT <italic toggle="yes">P</italic>-value</th><th align="center" rowspan="1" colspan="1">BCUnet</th><th align="center" rowspan="1" colspan="1">CORADS</th><th align="center" rowspan="1" colspan="1">CLARA</th><th align="center" rowspan="1" colspan="1">Pneumonia</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">BCUnet</td><td align="char" char="." rowspan="1" colspan="1">1.000000e+00</td><td align="char" char="." rowspan="1" colspan="1">4.428678e&#x02212;13*</td><td align="char" char="." rowspan="1" colspan="1">2.784633e&#x02212;17*</td><td align="char" char="." rowspan="1" colspan="1">2.176567e&#x02212;37*</td></tr><tr><td align="left" rowspan="1" colspan="1">CORADS</td><td align="char" char="." rowspan="1" colspan="1">4.428678e&#x02212;13</td><td align="char" char="." rowspan="1" colspan="1">1.000000e+00</td><td align="char" char="." rowspan="1" colspan="1">1.000000e+00</td><td align="char" char="." rowspan="1" colspan="1">3.274795e&#x02212;07</td></tr><tr><td align="left" rowspan="1" colspan="1">CLARA</td><td align="char" char="." rowspan="1" colspan="1">2.784633e&#x02212;17</td><td align="char" char="." rowspan="1" colspan="1">1.000000e+00</td><td align="char" char="." rowspan="1" colspan="1">1.000000e+00</td><td align="char" char="." rowspan="1" colspan="1">1.255710e-04</td></tr><tr><td align="left" rowspan="1" colspan="1">Pneumonia</td><td align="char" char="." rowspan="1" colspan="1">2.176567e&#x02212;37*</td><td align="char" char="." rowspan="1" colspan="1">3.274795e&#x02212;07*</td><td align="char" char="." rowspan="1" colspan="1">1.255710e&#x02212;04*</td><td align="char" char="." rowspan="1" colspan="1">1.000000e+00</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>* indicates significance with P &#x0003c; .01. Highlighted rows represent
which algorithm differs.</p></fn></table-wrap-foot></table-wrap></p><p>According to <italic toggle="yes">P</italic>-values in <xref rid="table2-15593258221082896" ref-type="table">Table 2</xref>, BCUnet differs from the other
tools (<italic toggle="yes">P</italic>-value &#x0003c; .01 rejects the null hypothesis of no
differences) meaning that CORADS, CLARA and Pneumonia tools generate similar CD-CT
CV% values. Instead, in <xref rid="table3-15593258221082896" ref-type="table">Table
3</xref> it is highlighted that BCUnet and Pneumonia tools differ on ULD-CT CV%
values estimation. Therefore, although the segmentation results have been generated
by different AI algorithms, it has been demonstrated that these algorithms give
comparable results, in terms of CV% values, regardless of the CT dose protocols. In
fact, for a qualitative demonstration, <xref rid="fig2-15593258221082896" ref-type="fig">Figure 2</xref> shows that the resulting CV% values
distributions of each AI tool are comparable for both dose protocols. The
non-Gaussian nature of the data can be also observed, according to Shapiro results.
Moreover, the overall trend of the boxplots matches the results of Dunn&#x02019;s test.<fig position="float" fig-type="figure" id="fig2-15593258221082896"><label>Figure 2.</label><caption><p>CD-CT and ULD-CT boxplots for all AI-based segmentation tools. Green
boxplots represent CD-CT CV% values, while pink boxplots represent
ULD-CT CV% values. The red line is the median value of plotted data; the
bars are the relative standard deviations and the dots are the
outliers.</p></caption><graphic xlink:href="10.1177_15593258221082896-fig2" position="float"/></fig></p><p>Regarding the correlation analysis, Spearman correlation coefficients (R) have been
carried out showing that all correlation coefficients are statistically significant.
<xref rid="fig3-15593258221082896" ref-type="fig">Figure 3</xref> shows the
heatmap of R values. The red-squared correlation coefficients refer to CD and ULD-CT
CV% values obtained by the same AI-based segmentation tool, highlighting a strong
correlation (R &#x0003e; .6), meaning that ULD-CT protocol can be used for a CV%
estimation comparable to CD-CT protocol, using all AI algorithms. To strengthen this
result, the pairwise (CD-CT and ULD-CT protocols) BA test has been applied on each
AI-based segmentation tool. <xref rid="fig4-15593258221082896" ref-type="fig">Figure
4</xref> shows BA results considering CD and ULD-CT CV% values, averaged over
all patients. The bias has been computed as the value determined by one CD-CT CV%
minus the value determined by the corresponding ULD-CT. The green dots represent the
paired difference between CD and ULD CV% values; the bold line is the mean of all
differences. As the plots in <xref rid="fig4-15593258221082896" ref-type="fig">Figure 4</xref> illustrate, the mean is around zero per each tool, confirming
that the bias (distance between zero line and mean line) is negligible. Moreover,
except for some outliers, most green dots do not exceed the maximum allowed
difference limits, according to which the differences within mean &#x000b1; 1.96&#x000a0;SD are
considered not relevant, demonstrating that the segmentation algorithms can work
similarly if they use CD-CT data and ULD-CT ones.<fig position="float" fig-type="figure" id="fig3-15593258221082896"><label>Figure 3.</label><caption><p>Spearman correlation coefficient heatmap. R values range in [&#x02212;1, 1]
interval.</p></caption><graphic xlink:href="10.1177_15593258221082896-fig3" position="float"/></fig><fig position="float" fig-type="figure" id="fig4-15593258221082896"><label>Figure 4.</label><caption><p>BA plots generated using paired values, that is, CD-CT and ULD-CT CV%
values, obtained from BCUnet, CORADS, CLARA, and Pneumonia tools. The
black line is the mean of differences between two measurements; the
dashed lines represent the test constraints (mean &#x02212;1.96&#x000a0;std/mean +1.96
std) and the dots are the paired differences of the two measurements
(both dose protocols) for each patient.</p></caption><graphic xlink:href="10.1177_15593258221082896-fig4" position="float"/></fig></p><p>After reaching the previous results from CV% data calculated with AI segmentation
algorithms on total lungs, these assays have been verified on data obtained with
lung lobe lesion segmentation algorithms, using BCUnet and CORADS tools. Data under
statistics were the lung lobe COVID-19 lesion volume percentage for each patient and
each protocol, as explained in &#x0201c;Statistical analysis&#x0201d; section. Hence, data have been
proved non-parametric according to the Shapiro test (P &#x0003c; .01), and also using
lobe segmentation, BCUnet and CORADS tools result different according to the KW
test. Since we implemented only two AI tools for lung lobe segmentation, Dunn&#x02019;s test
has not been applied. Considering correlation analysis, LLL%, LUL%, RLL%, RLM%, and
RUL% data show significant R values, between CD-CT and ULD-CT protocol, greater than
.66 for BCUnet tool (red squares in <xref rid="fig5-15593258221082896" ref-type="fig">Figure 5</xref>) and greater than .51 for CORADS
tool (green squares in <xref rid="fig5-15593258221082896" ref-type="fig">Figure
5</xref>).<fig position="float" fig-type="figure" id="fig5-15593258221082896"><label>Figure 5.</label><caption><p>Spearman correlation coefficient heatmap for lung lobe lesions volume
percentage on CD and ULD-CT protocols. R values range in [&#x02212;1, 1]
interval.</p></caption><graphic xlink:href="10.1177_15593258221082896-fig5" position="float"/></fig></p><p>In <xref rid="fig6-15593258221082896" ref-type="fig">Figure 6</xref>, BA plots on
LLL%, LUL%, RLL%, RLM%, and RUL% of BCUnet tool are presented. The paired
measurements are contained in the allowed limits. OnlyRLM% BA plot shows more
scattered data, always staying in the confidence interval limits. In <xref rid="fig7-15593258221082896" ref-type="fig">Figure 7</xref>, BA plots on LLL%,
LUL%, RLL%, RLM%, and RUL% of CORADS tool are shown. As in the previous plots, a low
bias is obtained and paired measurements are contained in the allowed limits, as
explained in the captions of <xref rid="fig6-15593258221082896" ref-type="fig">Figure 6</xref> and <xref rid="fig7-15593258221082896" ref-type="fig">Figure
7</xref>. These last results confirm that AI-based segmentation tools took out
comparable outcomes when obtained on both CD-CT and ULD-CT data.<fig position="float" fig-type="figure" id="fig6-15593258221082896"><label>Figure 6.</label><caption><p>BA plots generated using paired values, examined on LLL%, LUL%, RLL%,
RLM%, and RUL% of BCUnet tool. The black line is the mean of differences
between two measurements; the dashed lines represent the test limits
(mean &#x02212;1.96&#x000a0;std/mean +1.96&#x000a0;std) and the dots are the paired differences
of the two measurements (both dose protocols) for each patient.</p></caption><graphic xlink:href="10.1177_15593258221082896-fig6" position="float"/></fig><fig position="float" fig-type="figure" id="fig7-15593258221082896"><label>Figure 7.</label><caption><p>BA plots generated using paired values, examined on LLL%, LUL%, RLL%,
RLM%, and RUL% of CORADS tool. The black line is the mean of differences
between two measurements; the dashed lines represent the test limits
(mean &#x02212;1.96&#x000a0;std/mean +1.96&#x000a0;std) and the dots are the paired differences
of the two measurements (both dose protocols) for each patient.</p></caption><graphic xlink:href="10.1177_15593258221082896-fig7" position="float"/></fig></p></sec><sec sec-type="discussion" id="sec12-15593258221082896"><title>Discussion</title><p>AI-based tools supporting radiological evaluation can offer significant benefit in
clinical practice. COVID-19 pandemic has led to the development and refinement of AI
algorithms for disease diagnosis and monitoring, in particular for the automation of
lesion segmentations on CT images. However, the reliability of AI-based techniques
requires careful evaluation of the reproducibility with respect to the use of
different acquisition techniques. Furthermore, lack of knowledge of COVID-19 disease
felt the need to increase monitoring for fast diagnosis and reliable prevention,
leading patients to greater radiological exposure. Thus, low dose protocols for CT
scans have been implemented.<sup>
<xref rid="bibr18-15593258221082896" ref-type="bibr">20</xref>
</sup></p><p>In this work, the agreement of AI-based COVID-19 lung lesions segmentation methods
between chest CT images acquired following both CD-CT and ULD-CT protocols has been
evaluated for the first time. Four different DL-based segmentation tools, trained on
CD-CT protocol images, have been considered. The CV% parameter has been calculated
on both dose protocols data, allowing such statistical inferences. First of all, the
data showed on average a behavior far from a Gaussian distribution, thus
implementing non-parametric tests (e.g., KW test). The AI tools have been pairwise
compared to estimate their differences when applied on both dose protocols. As shown
by the Spearman correlation coefficients (R &#x0003e; .6 and <italic toggle="yes">P</italic>-value
&#x0003c; .05), a good agreement between CD and ULD-CT CV% values has resulted, confirmed
by the BA test (<xref rid="fig4-15593258221082896" ref-type="fig">Figure 4</xref>).
However, although the lack of diagnostic support tools trained on specific ULD-CT
data, it does not represent a critical limitation, since suitability of AI tools
designed on conventional datasets have been proved. Besides, the reliability of ULD
protocols has been already demonstrated on comparable diagnostic performance
evaluation for viral pneumonia detection on CT images,<sup><xref rid="bibr33-15593258221082896" ref-type="bibr">39</xref><xref rid="bibr34-15593258221082896" ref-type="bibr"/>-<xref rid="bibr35-15593258221082896" ref-type="bibr">41</xref></sup> but these results can
consolidate the role of ULD-CT in clinical routine with the undeniable advantage of
high dose reduction rate. This study should be considered as a preliminary
investigation, since it requires further development for a comprehensive evaluation.
Indeed, the application of retrospective noise reduction algorithms<sup>
<xref rid="bibr36-15593258221082896" ref-type="bibr">42</xref>
</sup> should be evaluated to improve the results of conventional algorithms on
ULD-CT data. In addition, the inclusion of ULD-CT data for AI model training should
be assessed. Noteworthy, the patients&#x02019; body mass index (BMI) may have a considerable
effect on the signal to noise ratio of the resulting ULD-CT images,<sup><xref rid="bibr37-15593258221082896" ref-type="bibr">43</xref>,<xref rid="bibr38-15593258221082896" ref-type="bibr">44</xref></sup> and
consequently on the analyzed algorithms&#x02019; results. The influence of BMI on the
results agreement relative to both ULD-CT and CD-CT protocols deserves to be further
investigated.</p><p>Among the examinations considered, a limitation of the present study is an unrevealed
quantifiable lesion load. In order to mitigate this limitation, two different
segmentation tasks have been considered, that is, lung and lobes segmentation.
Although it is a very specific work, our approach can also be applied to other
anatomical sectors, analyzing different classification tasks.<sup><xref rid="bibr39-15593258221082896" ref-type="bibr">45</xref><xref rid="bibr40-15593258221082896" ref-type="bibr"/><xref rid="bibr41-15593258221082896" ref-type="bibr"/><xref rid="bibr42-15593258221082896" ref-type="bibr"/><xref rid="bibr43-15593258221082896" ref-type="bibr"/>-<xref rid="bibr44-15593258221082896" ref-type="bibr">50</xref></sup> In conclusion, this work
investigates the applicability of automatic segmentation techniques, trained on
CD-CT protocol, to the images acquired in ULD mode. This preliminary study confirms
the suitability of available AI-based segmentation tools on ULD-CT data, for
supporting diagnosis and quantification of COVID-19 lung lesions.</p></sec></body><back><fn-group><fn fn-type="presented-by"><p><bold>Authors Contributions:</bold> MA and CC: conceived and designed the work. DB and CC: CT acquisition. GE, MV,
MA, DB, MR: data elaboration and analysis; MA, GE: writing and editing; CC, MS:
revision.</p></fn><fn fn-type="COI-statement"><p><bold>Declaration of Conflicting Interests:</bold> The authors declared no potential conflicts of interest with respect to the
research, authorship, and/or publication of this article.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> The authors disclosed receipt of the following financial support for the
research, authorship, and publication of this article: This work was partially
funded by the Italian Ministry of Health for the &#x0201c;Ricerca Corrente&#x0201d; project and
by POR CAMPANIA FESR 2014 - 2020 for the &#x0201c;Protocolli TC del torace a bassissima
dose e tecniche di intelligenza artificiale per la diagnosi precoce e
quantificazione della malattia da COVID-19&#x0201d; project.</p></fn></fn-group><sec id="sec16-15593258221082896"><title>ORCID iDs</title><p>Marco Aiello <ext-link xlink:href="https://orcid.org/0000-0002-3676-0664" ext-link-type="uri">https://orcid.org/0000-0002-3676-0664</ext-link></p><p>Dario Baldi <ext-link xlink:href="https://orcid.org/0000-0001-7464-4499" ext-link-type="uri">https://orcid.org/0000-0001-7464-4499</ext-link></p><p>Carlo Cavaliere <ext-link xlink:href="https://orcid.org/0000-0002-3297-2213" ext-link-type="uri">https://orcid.org/0000-0002-3297-2213</ext-link></p></sec><ref-list><title>References</title><ref id="bibr48-15593258221082896"><label>1</label><mixed-citation publication-type="other"><comment>WHO dashboard, consulted on
08/04/2021</comment>. <ext-link xlink:href="https://covid19.who.int/" ext-link-type="uri">https://covid19.who.int/</ext-link>.</mixed-citation></ref><ref id="bibr1-15593258221082896"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tahamtan</surname><given-names>A</given-names></name>
<name><surname>Ardebili</surname><given-names>A</given-names></name>
</person-group>. <article-title>Real-time RT-PCR in COVID-19 detection: issues
affecting the results</article-title>. <source>Expert Rev Mol
Diagn</source>. <year>2020</year>; <volume>20</volume>:
<fpage>453</fpage>-<lpage>454</lpage>. doi:<pub-id pub-id-type="doi">10.1080/14737159.2020.1757437</pub-id>.<pub-id pub-id-type="pmid">32297805</pub-id></mixed-citation></ref><ref id="bibr2-15593258221082896"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chung</surname><given-names>M</given-names></name>
<name><surname>Bernheim</surname><given-names>A</given-names></name>
<name><surname>Mei</surname><given-names>X</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>CT imaging features of 2019 novel coronavirus
(2019-nCoV)</article-title>. <source>Radiology</source>.
<year>2020</year>;<volume>295</volume>:<fpage>202</fpage>-<lpage>207</lpage>.
doi:<pub-id pub-id-type="doi">10.1148/radiol.2020200230</pub-id>.<pub-id pub-id-type="pmid">32017661</pub-id></mixed-citation></ref><ref id="bibr3-15593258221082896"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>G</given-names></name>
<name><surname>Gong</surname><given-names>T</given-names></name>
<name><surname>Wang</surname><given-names>G</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Timely diagnosis and treatment shortens the time to resolution of
coronavirus disease (COVID-19) pneumonia and lowers the highest and last CT
scores from sequential chest CT</article-title>. <source>Am J
Roentgenol</source>.
<year>2020</year>;<volume>215</volume>:<fpage>367</fpage>-<lpage>373</lpage>.
doi:<pub-id pub-id-type="doi">10.2214/AJR.20.23078</pub-id>.<pub-id pub-id-type="pmid">32223665</pub-id></mixed-citation></ref><ref id="bibr4-15593258221082896"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bandirali</surname><given-names>M</given-names></name>
<name><surname>Sconfienza</surname><given-names>LM</given-names></name>
<name><surname>Serra</surname><given-names>R</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Chest radiograph findings in asymptomatic and minimally
symptomatic quarantined patients in codogno, Italy during COVID-19
pandemic</article-title>. <source>Radiology</source>.
<year>2020</year>;<volume>295</volume>:<fpage>E7</fpage>. doi:<pub-id pub-id-type="doi">10.1148/radiol.2020201102</pub-id>.<pub-id pub-id-type="pmid">32216718</pub-id></mixed-citation></ref><ref id="bibr5-15593258221082896"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rubin</surname><given-names>GD</given-names></name>
<name><surname>Ryerson</surname><given-names>CJ</given-names></name>
<name><surname>Haramati</surname><given-names>LB</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>The role of chest imaging in patient management during the
COVID-19 pandemic: a multinational consensus statement from the fleischner
society</article-title>. <source>Radiology</source>.
<year>2020</year>;<volume>296</volume>(<issue>1</issue>):<fpage>172</fpage>-<lpage>180</lpage>.
doi:<pub-id pub-id-type="doi">10.1148/radiol.2020201365</pub-id>.<pub-id pub-id-type="pmid">32255413</pub-id></mixed-citation></ref><ref id="bibr49-15593258221082896"><label>7</label><mixed-citation publication-type="other"><person-group person-group-type="author">
<collab>WHO publications</collab>
</person-group>, <comment>consulted on 08/04/2021, &#x02018;&#x02019;Use of chest imaging in
COVID19&#x0201d;</comment>. <ext-link xlink:href="https://www.who.int/publications/i/item/use-of-chest-imaging-in-covid-19" ext-link-type="uri">https://www.who.int/publications/i/item/use-of-chest-imaging-in-covid-19</ext-link></mixed-citation></ref><ref id="bibr6-15593258221082896"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brenner</surname><given-names>DJ</given-names></name>
<name><surname>Elliston</surname><given-names>CD</given-names></name>
<name><surname>Hall</surname><given-names>EJ</given-names></name>
<name><surname>Berdon</surname><given-names>WE</given-names></name>
</person-group>. <article-title>Estimated risks of radiation-induced fatal
cancer from pediatric CT</article-title>. <source>AJR Am J
Roentgenol</source>.
<year>2001</year>;<volume>176</volume>:<fpage>289</fpage>-<lpage>296</lpage>.
doi:<pub-id pub-id-type="doi">10.2214/ajr.176.2.1760289</pub-id>.<pub-id pub-id-type="pmid">11159059</pub-id></mixed-citation></ref><ref id="bibr7-15593258221082896"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Greess</surname><given-names>H</given-names></name>
<name><surname>Wolf</surname><given-names>H</given-names></name>
<name><surname>Baum</surname><given-names>U</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Dose reduction in computed tomography by attenuation-based
on-line modulation of tube current: evaluation of six anatomical
regions</article-title>. <source>Eur Radiol</source>.
<year>2000</year>;<volume>10</volume>:<fpage>391</fpage>-<lpage>394</lpage>.
doi:<pub-id pub-id-type="doi">10.1007/s003300050062</pub-id>.<pub-id pub-id-type="pmid">10663775</pub-id></mixed-citation></ref><ref id="bibr8-15593258221082896"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Toth</surname><given-names>TL</given-names></name>
</person-group>. <article-title>Dose reduction opportunities for CT
scanners</article-title>. <source>Pediatr Radiol</source>.
<year>2002</year>;<volume>32</volume>:<fpage>261</fpage>-<lpage>267</lpage>.
doi:<pub-id pub-id-type="doi">10.1007/s00247-002-0678-7</pub-id>.<pub-id pub-id-type="pmid">11956707</pub-id></mixed-citation></ref><ref id="bibr9-15593258221082896"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Haaga</surname><given-names>JR</given-names></name>
</person-group>. <article-title>Radiation dose management</article-title>.
<source>Am J Roentgenol</source>.
<year>2001</year>;<volume>177</volume>:<fpage>289</fpage>-<lpage>291</lpage>.
doi:<pub-id pub-id-type="doi">10.2214/ajr.177.2.1770289</pub-id>.<pub-id pub-id-type="pmid">11461847</pub-id></mixed-citation></ref><ref id="bibr10-15593258221082896"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Diederich</surname><given-names>S</given-names></name>
<name><surname>Lenzen</surname><given-names>H</given-names></name>
<name><surname>Windmann</surname><given-names>R</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Pulmonary nodules: experimental and clinical studies at low-dose
CT</article-title>. <source>Radiology</source>.
<year>1999</year>;<volume>213</volume>:<fpage>289</fpage>-<lpage>298</lpage>.
doi:<pub-id pub-id-type="doi">10.1148/radiology.213.1.r99oc29289</pub-id>.<pub-id pub-id-type="pmid">10540674</pub-id></mixed-citation></ref><ref id="bibr11-15593258221082896"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jurik</surname><given-names>AG</given-names></name>
<name><surname>Jessen</surname><given-names>KA</given-names></name>
<name><surname>Hansen</surname><given-names>J</given-names></name>
</person-group>. <article-title>Image quality and dose in computed
tomography</article-title>. <source>Eur Radiol</source>.
<year>1997</year>;<volume>7</volume>:<fpage>77</fpage>-<lpage>81</lpage>.
doi:<pub-id pub-id-type="doi">10.1007/s003300050114</pub-id>.<pub-id pub-id-type="pmid">9000403</pub-id></mixed-citation></ref><ref id="bibr12-15593258221082896"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mayo</surname><given-names>JR</given-names></name>
<name><surname>Hartman</surname><given-names>TE</given-names></name>
<name><surname>Lee</surname><given-names>KS</given-names></name>
<name><surname>Primack</surname><given-names>SL</given-names></name>
<name><surname>Vedal</surname><given-names>S</given-names></name>
<name><surname>M&#x000fc;ller</surname><given-names>NL</given-names></name>
</person-group>. <article-title>CT of the chest: minimal tube current required
for good image quality with the least radiation dose</article-title>.
<source>Am J Roentgenol</source>.
<year>1995</year>;<volume>164</volume>:<fpage>603</fpage>-<lpage>607</lpage>.
doi:<pub-id pub-id-type="doi">10.2214/ajr.164.3.7863879</pub-id>.<pub-id pub-id-type="pmid">7863879</pub-id></mixed-citation></ref><ref id="bibr13-15593258221082896"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Naidich</surname><given-names>DP</given-names></name>
<name><surname>Marshall</surname><given-names>CH</given-names></name>
<name><surname>Gribbin</surname><given-names>C</given-names></name>
<name><surname>Arams</surname><given-names>RS</given-names></name>
<name><surname>McCauley</surname><given-names>DI</given-names></name>
</person-group>. <article-title>Low-dose CT of the lungs: preliminary
observations</article-title>. <source>Radiology</source>.
<year>1990</year>;<volume>175</volume>:<fpage>729</fpage>-<lpage>731</lpage>.
doi:<pub-id pub-id-type="doi">10.1148/radiology.175.3.2343122</pub-id>.<pub-id pub-id-type="pmid">2343122</pub-id></mixed-citation></ref><ref id="bibr14-15593258221082896"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rusinek</surname><given-names>H</given-names></name>
<name><surname>Naidich</surname><given-names>DP</given-names></name>
<name><surname>McGuinness</surname><given-names>G</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Pulmonary nodule detection: low-dose versus conventional
CT</article-title>. <source>Radiology</source>.
<year>1998</year>;<volume>209</volume>:<fpage>243</fpage>-<lpage>249</lpage>.
doi:<pub-id pub-id-type="doi">10.1148/radiology.209.1.9769838</pub-id>.<pub-id pub-id-type="pmid">9769838</pub-id></mixed-citation></ref><ref id="bibr15-15593258221082896"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ware</surname><given-names>DE</given-names></name>
<name><surname>Huda</surname><given-names>W</given-names></name>
<name><surname>Mergo</surname><given-names>PJ</given-names></name>
<name><surname>Litwiller</surname><given-names>AL</given-names></name>
</person-group>. <article-title>Radiation effective doses to patients undergoing
abdominal CT examinations</article-title>. <source>Radiology</source>.
<year>1999</year>;
<volume>210</volume>:<fpage>645</fpage>-<lpage>650</lpage>. doi:<pub-id pub-id-type="doi">10.1148/radiology.210.3.r99mr05645</pub-id>.<pub-id pub-id-type="pmid">10207462</pub-id></mixed-citation></ref><ref id="bibr16-15593258221082896"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Baldi</surname><given-names>D</given-names></name>
<name><surname>Tramontano</surname><given-names>L</given-names></name>
<name><surname>Alfano</surname><given-names>V</given-names></name>
<name><surname>Punzo</surname><given-names>B</given-names></name>
<name><surname>Cavaliere</surname><given-names>C</given-names></name>
<name><surname>Salvatore</surname><given-names>M</given-names></name>
</person-group>. <article-title>Whole body low dose computed tomography using
third-generation dual-source multidetector with spectral shaping: protocol
optimization and literature review</article-title>.
<source>Dose-Response</source>. <year>2020</year> Dec
29;<volume>18</volume>(<issue>4</issue>). doi:<pub-id pub-id-type="doi">10.1177/1559325820973131</pub-id>.</mixed-citation></ref><ref id="bibr17-15593258221082896"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schaal</surname><given-names>M</given-names></name>
<name><surname>Severac</surname><given-names>F</given-names></name>
<name><surname>Labani</surname><given-names>A</given-names></name>
<name><surname>Jeung</surname><given-names>MY</given-names></name>
<name><surname>Roy</surname><given-names>C</given-names></name>
<name><surname>Ohana</surname><given-names>M</given-names></name>
</person-group>. <article-title>Diagnostic performance of ultra-low-dose
computed tomography for detecting asbestos-related pleuropulmonary diseases:
prospective study in a screening setting</article-title>. <source>PLoS
One</source>. <year>2016</year>;<volume>11</volume>:<fpage>e0168979</fpage>.
doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0168979</pub-id>.<pub-id pub-id-type="pmid">28033378</pub-id></mixed-citation></ref><ref id="bibr18-15593258221082896"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dangis</surname><given-names>A</given-names></name>
<name><surname>Gieraerts</surname><given-names>C</given-names></name>
<name><surname>De Bruecker</surname><given-names>Y</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Accuracy and reproducibility of low-dose submillisievert chest CT
for the diagnosis of COVID-19</article-title>. <source>Radiology:
Cardiothoracic Imaging</source>.
<year>2020</year>;<volume>2</volume>:<fpage>e200196</fpage>. doi:<pub-id pub-id-type="doi">10.1148/ryct.2020200196</pub-id>.<pub-id pub-id-type="pmid">33778576</pub-id></mixed-citation></ref><ref id="bibr19-15593258221082896"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Aggarwal</surname><given-names>R</given-names></name>
<name><surname>Sounderajah</surname><given-names>V</given-names></name>
<name><surname>Martin</surname><given-names>G</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Diagnostic accuracy of deep learning in medical imaging: a
systematic review and meta-analysis</article-title>. <source>NPJ digital
medicine</source>.
<year>2021</year>;<volume>4</volume>:<fpage>65</fpage>-23. doi:<pub-id pub-id-type="doi">10.1038/s41746-021-00438-z</pub-id>.<pub-id pub-id-type="pmid">33828217</pub-id></mixed-citation></ref><ref id="bibr20-15593258221082896"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lundervold</surname><given-names>AS</given-names></name>
<name><surname>Lundervold</surname><given-names>A</given-names></name>
</person-group>. <article-title>An overview of deep learning in medical imaging
focusing on MRI</article-title>. <source>Z Med Phys</source>.
<year>2019</year>;<volume>29</volume>:<fpage>102</fpage>-<lpage>127</lpage>.
doi:<pub-id pub-id-type="doi">10.1016/j.zemedi.2018.11.002</pub-id>.<pub-id pub-id-type="pmid">30553609</pub-id></mixed-citation></ref><ref id="bibr21-15593258221082896"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Saba</surname><given-names>L</given-names></name>
<name><surname>Agarwal</surname><given-names>M</given-names></name>
<name><surname>Patrick</surname><given-names>A</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Six artificial intelligence paradigms for tissue characterisation
and classification of non-COVID-19 pneumonia against COVID-19 pneumonia in
computed tomography lungs</article-title>. <source>Int J CARS</source>.
<year>2021</year>;16(3):423-434. doi:<pub-id pub-id-type="doi">10.1007/s11548-021-02317-0</pub-id>.</mixed-citation></ref><ref id="bibr22-15593258221082896"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kermany</surname><given-names>DS</given-names></name>
<name><surname>Goldbaum</surname><given-names>M</given-names></name>
<name><surname>Cai</surname><given-names>W</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Identifying medical diagnoses and treatable diseases by
image-based deep learning</article-title>. <source>Cell</source>.
<year>2018</year>;<volume>172</volume>:<fpage>1122</fpage>-<lpage>1131</lpage>.
<comment>e9</comment> doi:<pub-id pub-id-type="doi">10.1016/j.cell.2018.02.010</pub-id>.<pub-id pub-id-type="pmid">29474911</pub-id></mixed-citation></ref><ref id="bibr23-15593258221082896"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rajaraman</surname><given-names>S</given-names></name>
<name><surname>Candemir</surname><given-names>S</given-names></name>
<name><surname>Kim</surname><given-names>I</given-names></name>
<name><surname>Thoma</surname><given-names>G</given-names></name>
<name><surname>Antani</surname><given-names>S</given-names></name>
</person-group>. <article-title>Visualization and interpretation of
convolutional neural network predictions in detecting pneumonia in pediatric
chest radiographs</article-title>. <source>Appl Sci</source>.
<year>2018</year>;<volume>8</volume>:<fpage>1715</fpage>. doi:<pub-id pub-id-type="doi">10.3390/app8101715</pub-id>.<pub-id pub-id-type="pmid">32457819</pub-id></mixed-citation></ref><ref id="bibr24-15593258221082896"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>L</given-names></name>
<name><surname>Qin</surname><given-names>L</given-names></name>
<name><surname>Xu</surname><given-names>Z</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Using artificial intelligence to detect COVID-19 and
community-acquired pneumonia based on pulmonary CT: evaluation of the
diagnostic accuracy</article-title>. <source>Radiology</source>.
<year>2020</year>;<volume>296</volume>:<fpage>E65</fpage>-<lpage>E71</lpage>.
doi:<pub-id pub-id-type="doi">10.1148/radiol.2020200905</pub-id>.<pub-id pub-id-type="pmid">32191588</pub-id></mixed-citation></ref><ref id="bibr25-15593258221082896"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Harmon</surname><given-names>SA</given-names></name>
<name><surname>Sanford</surname><given-names>TH</given-names></name>
<name><surname>Xu</surname><given-names>S</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Artificial intelligence for the detection of COVID-19 pneumonia
on chest CT using multinational datasets</article-title>. <source>Nat
Commun</source>. <year>2020</year>;<volume>11</volume>:<fpage>4080</fpage>.
doi:<pub-id pub-id-type="doi">10.1038/s41467-020-17971-2</pub-id>.<pub-id pub-id-type="pmid">32796848</pub-id></mixed-citation></ref><ref id="bibr26-15593258221082896"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>J</given-names></name>
<name><surname>Wu</surname><given-names>CJ</given-names></name>
<name><surname>Bao</surname><given-names>ML</given-names></name>
<name><surname>Zhang</surname><given-names>J</given-names></name>
<name><surname>Wang</surname><given-names>XN</given-names></name>
<name><surname>Zhang</surname><given-names>YD</given-names></name>
</person-group>. <article-title>Machine learning-based analysis of MR radiomics
can help to improve the diagnostic performance of PI-RADS v2 in clinically
relevant prostate cancer</article-title>. <source>Eur Radiol</source>.
<year>2017</year>;<volume>27</volume>:<fpage>4082</fpage>-<lpage>4090</lpage>.
doi:<pub-id pub-id-type="doi">10.1007/s00330-017-4800-5</pub-id>.<pub-id pub-id-type="pmid">28374077</pub-id></mixed-citation></ref><ref id="bibr27-15593258221082896"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ronneberger</surname><given-names>O</given-names></name>
<name><surname>Fischer</surname><given-names>P</given-names></name>
<name><surname>Brox</surname><given-names>T</given-names></name>
</person-group>. <article-title>U-net: convolutional networks for biomedical
image segmentation</article-title>. <source>Presented at the
MICCAI</source>.
<year>2015</year>;<volume>9351</volume>:<fpage>234</fpage>-<lpage>241</lpage>.</mixed-citation></ref><ref id="bibr28-15593258221082896"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Roth</surname><given-names>H</given-names></name>
<name><surname>Xu</surname><given-names>Z</given-names></name>
<name><surname>Diez</surname><given-names>CT</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Rapid artificial intelligence solutions in a pandemic - the
COVID-19-20 lung CT lesion segmentation challenge</article-title>.
<source>Res Sq</source>.
<year>2021</year>;<volume>1</volume>:<fpage>571332</fpage>. doi:<pub-id pub-id-type="doi">10.21203/rs.3.rs-571332/v1</pub-id>.</mixed-citation></ref><ref id="bibr29-15593258221082896"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lessmann</surname><given-names>N</given-names></name>
<name><surname>S&#x000e1;nchez</surname><given-names>CI</given-names></name>
<name><surname>Beenen</surname><given-names>L</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Automated assessment of CO-RADS and chest CT severity scores in
patients with suspected COVID-19 using artificial
intelligence</article-title>. <source>Radiology</source>.
<year>2020</year>;298(1):<fpage>202439</fpage>. doi:<pub-id pub-id-type="doi">10.1148/radiol.2020202439</pub-id>.</mixed-citation></ref><ref id="bibr30-15593258221082896"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chaganti</surname><given-names>S</given-names></name>
<name><surname>Grenier</surname><given-names>P</given-names></name>
<name><surname>Balachandran</surname><given-names>A</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Automated quantification of CT patterns associated with COVID-19
from chest CT</article-title>. <source>Radiol Artif Intell</source>.
<year>2020</year>;<volume>2</volume>:<fpage>e200048</fpage>. doi:<pub-id pub-id-type="doi">10.1148/ryai.2020200048</pub-id>.<pub-id pub-id-type="pmid">33928255</pub-id></mixed-citation></ref><ref id="bibr47-15593258221082896"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shapiro</surname><given-names>SS</given-names></name>
<name><surname>Wilk</surname><given-names>MB</given-names></name>
</person-group>. <article-title>An analysis of variance test for normality
(complete samples)</article-title>. <source>Biometrika</source>.
<year>1965</year>;<volume>52</volume>:<fpage>591</fpage>-<lpage>611</lpage>.</mixed-citation></ref><ref id="bibr46-15593258221082896"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kruskal</surname><given-names>WH</given-names></name>
<name><surname>Wallis</surname><given-names>WW</given-names></name>
</person-group>. <article-title>Use of ranks in one-criterion variance
analysis</article-title>. <source>J Am Stat Assoc</source>.
<year>1952</year>;<volume>47</volume>(<issue>Issue
260</issue>):<fpage>583</fpage>-<lpage>621</lpage>.</mixed-citation></ref><ref id="bibr45-15593258221082896"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dunn</surname><given-names>OJ</given-names></name>
</person-group>. <article-title>Multiple comparisons using rank
sums</article-title>. <source>Technometrics</source>.
<year>1964</year>;<volume>6</volume>:<fpage>241</fpage>-<lpage>252</lpage>.</mixed-citation></ref><ref id="bibr31-15593258221082896"><label>36</label><mixed-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Zwillinger</surname><given-names>D</given-names></name>
<name><surname>Kokoska</surname><given-names>S</given-names></name>
</person-group>. <source>CRC Standard Probability and Statistics Tables and
Formulae</source>. <publisher-loc>New
York</publisher-loc>:<publisher-name>Chapman &#x00026;
Hall</publisher-name>;<year>2000</year>:<fpage>7</fpage>. <comment>Section
14</comment>.</mixed-citation></ref><ref id="bibr32-15593258221082896"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Altman</surname><given-names>DG</given-names></name>
<name><surname>Bland</surname><given-names>JM</given-names></name>
</person-group>. <article-title>Measurement in medicine: the analysis of method
comparison studies</article-title>. <source>Journal of the Royal Statistical
Society. Series D (The Statistician)</source>.
<year>1983</year>;<volume>32</volume>:<fpage>307</fpage>-<lpage>317</lpage>.
doi:<pub-id pub-id-type="doi">10.2307/2987937</pub-id>.</mixed-citation></ref><ref id="bibr50-15593258221082896"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name> and <name><surname>Xie</surname><given-names>X</given-names></name></person-group>. <article-title>Automatic pulmonary lobe segmentation
using deep learning</article-title>. <source>In: 2019 IEEE 16th
international symposium on biomedical imaging (ISBI 2019)</source>
<year>2019</year>;<fpage>1225</fpage>-<lpage>1228</lpage>. doi:<pub-id pub-id-type="doi">10.1109/ISBI.2019.8759468</pub-id>.</mixed-citation></ref><ref id="bibr33-15593258221082896"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Argentieri</surname><given-names>G</given-names></name>
<name><surname>Bellesi</surname><given-names>L</given-names></name>
<name><surname>Pagnamenta</surname><given-names>A</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Diagnostic yield, safety, and advantages of ultra-low dose chest
CT compared to chest radiography in early stage suspected SARS-CoV-2
pneumonia</article-title>. <source>Medicine</source>.
<year>2021</year>;<volume>100</volume>:<fpage>e26034</fpage>. doi:<pub-id pub-id-type="doi">10.1097/MD.0000000000026034</pub-id>.<pub-id pub-id-type="pmid">34032725</pub-id></mixed-citation></ref><ref id="bibr34-15593258221082896"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Greffier</surname><given-names>J</given-names></name>
<name><surname>Hoballah</surname><given-names>A</given-names></name>
<name><surname>Sadate</surname><given-names>A</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Ultra-low-dose chest CT performance for the detection of viral
pneumonia patterns during the COVID-19 outbreak period: a monocentric
experience</article-title>. <source>Quant Imag Med Surg</source>.
<year>2021</year>;<volume>11</volume>:<fpage>3190</fpage>-<lpage>3199</lpage>.
doi:<pub-id pub-id-type="doi">10.21037/qims-20-1176</pub-id>.</mixed-citation></ref><ref id="bibr35-15593258221082896"><label>41</label><mixed-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Zarei</surname><given-names>F</given-names></name>
<name><surname>Jalli</surname><given-names>R</given-names></name>
<name><surname>Chatterjee</surname><given-names>S</given-names></name>
</person-group>, <etal>et al.</etal>
<source>Evaluation of Ultra Low Dose Chest CT Imaging for Covid 19 Diagnosis and
Follow up</source>; <year>2020</year>. <comment>arXiv:2005.03347
[physics]</comment>.</mixed-citation></ref><ref id="bibr36-15593258221082896"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mohammadinejad</surname><given-names>P</given-names></name>
<name><surname>Mileto</surname><given-names>A</given-names></name>
<name><surname>Yu</surname><given-names>L</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>CT noise-reduction methods for lower-dose scanning: strengths and
weaknesses of iterative reconstruction algorithms and new
techniques</article-title>. <source>Radiographics</source>.
<year>2021</year>;<volume>41</volume>:<fpage>1493</fpage>-<lpage>1508</lpage>.
doi:<pub-id pub-id-type="doi">10.1148/rg.2021200196</pub-id>.<pub-id pub-id-type="pmid">34469209</pub-id></mixed-citation></ref><ref id="bibr37-15593258221082896"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Qurashi</surname><given-names>AA</given-names></name>
<name><surname>Rainford</surname><given-names>LA</given-names></name>
<name><surname>Alhazmi</surname><given-names>FH</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Low radiation dose implications in obese abdominal computed
tomography imaging</article-title>. <source>Appl Sci</source>.
<year>2021</year>;<volume>11</volume>:<fpage>2456</fpage>. doi:<pub-id pub-id-type="doi">10.3390/app11062456</pub-id>.</mixed-citation></ref><ref id="bibr38-15593258221082896"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Qurashi</surname><given-names>AA</given-names></name>
<name><surname>Rainford</surname><given-names>LA</given-names></name>
<name><surname>Alshamrani</surname><given-names>KM</given-names></name>
<name><surname>Foley</surname><given-names>SJ</given-names></name>
</person-group>. <article-title>The impact of obesity on abdominal Ct radiation
dose and image quality</article-title>. <source>Radiat Prot
Dosimetry</source>.
<year>2019</year>;<volume>185</volume>:<fpage>17</fpage>-<lpage>26</lpage>.
doi:<pub-id pub-id-type="doi">10.1093/rpd/ncy212</pub-id>.<pub-id pub-id-type="pmid">30508172</pub-id></mixed-citation></ref><ref id="bibr39-15593258221082896"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ahn</surname><given-names>Y</given-names></name>
<name><surname>Yoon</surname><given-names>JS</given-names></name>
<name><surname>Lee</surname><given-names>SS</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Deep learning algorithm for automated segmentation and volume
measurement of the liver and spleen using portal venous phase computed
tomography images</article-title>. <source>Korean J Radiol</source>.
<year>2020</year>;<volume>21</volume>:<fpage>987</fpage>-<lpage>997</lpage>.
doi:<pub-id pub-id-type="doi">10.3348/kjr.2020.0237</pub-id>.<pub-id pub-id-type="pmid">32677383</pub-id></mixed-citation></ref><ref id="bibr40-15593258221082896"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Borrelli</surname><given-names>P</given-names></name>
<name><surname>Kaboteh</surname><given-names>R</given-names></name>
<name><surname>Enqvist</surname><given-names>O</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Artificial intelligence-aided CT segmentation for body
composition analysis: a validation study</article-title>. <source>European
Radiology Experimental</source>.
<year>2021</year>;<volume>5</volume>:<fpage>11</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s41747-021-00210-8</pub-id>.<pub-id pub-id-type="pmid">33694046</pub-id></mixed-citation></ref><ref id="bibr41-15593258221082896"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>H</given-names></name>
<name><surname>Troschel</surname><given-names>FM</given-names></name>
<name><surname>Tajmir</surname><given-names>S</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Pixel-level deep segmentation: artificial intelligence quantifies
muscle on computed tomography for body morphometric
analysis</article-title>. <source>J Digit Imag</source>.
<year>2017</year>;<volume>30</volume>:<fpage>487</fpage>-<lpage>498</lpage>.
doi:<pub-id pub-id-type="doi">10.1007/s10278-017-9988-z</pub-id>.</mixed-citation></ref><ref id="bibr42-15593258221082896"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lindgren Belal</surname><given-names>S</given-names></name>
<name><surname>Sadik</surname><given-names>M</given-names></name>
<name><surname>Kaboteh</surname><given-names>R</given-names></name>
</person-group>, <etal>et al.</etal>
<article-title>Deep learning for segmentation of 49 selected bones in CT scans:
first step in automated PET/CT-based 3D quantification of skeletal
metastases</article-title>. <source>Eur J Radiol</source>.
<year>2019</year>;<volume>113</volume>:<fpage>89</fpage>-<lpage>95</lpage>.
doi:<pub-id pub-id-type="doi">10.1016/j.ejrad.2019.01.028</pub-id>.<pub-id pub-id-type="pmid">30927965</pub-id></mixed-citation></ref><ref id="bibr43-15593258221082896"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Paris</surname><given-names>MT</given-names></name>
</person-group>. <article-title>Body composition analysis of computed tomography
scans in clinical populations: the role of deep learning</article-title>.
<source>LFG</source>.
<year>2020</year>;<volume>13</volume>:<fpage>28</fpage>-<lpage>31</lpage>.
doi:<pub-id pub-id-type="doi">10.1159/000503996</pub-id>.</mixed-citation></ref><ref id="bibr44-15593258221082896"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rister</surname><given-names>B</given-names></name>
<name><surname>Yi</surname><given-names>D</given-names></name>
<name><surname>Shivakumar</surname><given-names>K</given-names></name>
<name><surname>Nobashi</surname><given-names>T</given-names></name>
<name><surname>Rubin</surname><given-names>DL</given-names></name>
</person-group>. <article-title>CT-ORG, a new dataset for multiple organ
segmentation in computed tomography</article-title>. <source>Sci
Data</source>. <year>2020</year>;<volume>7</volume>:<fpage>381</fpage>.
doi:<pub-id pub-id-type="doi">10.1038/s41597-020-00715-8</pub-id>.<pub-id pub-id-type="pmid">33177518</pub-id></mixed-citation></ref></ref-list></back></article>
